source
- Novo outlines plan for multiple new drugs to regain market share as shares dip 8%At a capital markets day in London, Novo executives presented a roadmap to launch more than five multi-blockbuster drugs by 2030 and target $23 billion in annual sales by 2035, aiming to offset the…
- Walgreens Specialty Pharmacy highlights holistic support to boost oncology medication adherenceAdvances in oncology are moving care out of the clinic and into patients' homes, with treatments becoming more personalized. This shift means patients often manage complex drug schedules themselves…